findmyKOL

David Goldfarb, MD

Enriched profile

Clinical Chief, Nephrology Division, NYU Langone Health; Professor of Medicine and Neuroscience, NYU Grossman School of Medicine · NYU Grossman School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyNephrologyFocusKidney Stones and Urolithiasis Treatments+4
Active KOLfindmyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1986–2026

David Goldfarb is Clinical Chief, Nephrology Division, NYU Langone Health; Professor of Medicine and Neuroscience, NYU Grossman School of Medicine at NYU Grossman School of Medicine. OpenAlex indexes 500 publications with 23,611 citations (h-index 81); ClinicalTrials.gov lists 19 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

David Goldfarb, M.D., is Clinical Chief, Nephrology Division, NYU Langone Health at NYU Grossman School of Medicine / NYU Langone Health. The public record shows 500 publications with 23,611 citations (h-index 81), centered on Kidney Stones and Urolithiasis Treatments, Pediatric Urology and Nephrology Studies, Dialysis and Renal Disease Management. It also documents an investigator role on 19 registered clinical trials, industry payments reported by 11 companies, 11 NIH-funded awards (1986–2026).

  • Most recent indexed publication: 2026 · Nature
  • Top research focus: Kidney Stones and Urolithiasis Treatments
  • 19 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 11 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cysts7 trialsCystinuria7 trialsKidney Calculi5 trialsLithiasis4 trialsHyperoxaluria4 trialsNephrolithiasis3 trialsDent Disease3 trialsUrolithiasis2 trialsHyperoxaluria, Primary2 trialsChronic Kidney Disease1 trialRenal Insufficiency, Chronic1 trialHyperkalemia1 trialAdenine phosphoribosyltransferase deficiency1 trialOculocerebrorenal Syndrome1 trialESRD / Dialysis

Research focus

OpenAlex concept fingerprint
Kidney Stones and Urolithiasis TreatmentsPediatric Urology and Nephrology StudiesDialysis and Renal Disease ManagementNuclear Structure and FunctionRNA Research and Splicing

Drugs & molecules

across trials, industry payments and publications
Rivflozageneric · NedosiranClinical trials—Industry payments2Publications2Oxlumogeneric · LumasiranClinical trials—Industry payments23Publications—Krystexxageneric · PegloticaseClinical trials—Industry payments2Publications—Veltassageneric · PatiromerClinical trials—Industry payments2Publications—Ozempicgeneric · SemaglutideClinical trials—Industry payments1Publications—Thiolageneric · TioproninClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Novo Nordisk IncClinical trials—Industry payments32Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments25NYU Langone HealthClinical trials9Industry payments—Novo Nordisk ASClinical trials—Industry payments6VA New York Harbor Healthcare SystemClinical trials6Industry payments—Travere Therapeutics, Inc.Clinical trials—Industry payments3Horizon Therapeutics plcClinical trials—Industry payments2Mayo ClinicClinical trials2Industry payments—Vifor Pharma, Inc.Clinical trials—Industry payments2Albert Einstein College of MedicineClinical trials1Industry payments—Eli Lilly and CompanyClinical trials—Industry payments1Foundation for Innovative New Diagnostics, SwitzerlandClinical trials1Industry payments—Novo Nordisk Health Care AGClinical trials—Industry payments1Sanofi Us Services Inc.Clinical trials—Industry payments1Sumitomo Dainippon Pharma Co., Ltd.Clinical trials—Industry payments1Sumitomo Pharma Co., Ltd.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
500publications

Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.

23,611citations

Total citations across indexed works.

81h-index

Hirsch index (OpenAlex). i10-index 281.

Clinical & industry

trials, payments and federal funding
19clinical trials

Investigator role on registered studies.

View trials ↓
11companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
11NIH grants · 1986–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    55.2%
    Metabolic Alkalinizer51.8%
    Potassium Citrate Er100%
    Part D≥57 patients
    Potassium supplement3.4%
    Potassium Chloride100%
    Part D<11 patients
  • Cardiovascular

    25%
    Thiazide-like diuretic18.8%
    Indapamide57%Chlorthalidone43%
    Part D<11 patients
    Loop diuretic3.4%
    Furosemide100%
    Part D<11 patients

    + 1 more class in this area

  • Nervous system

    7.3%
    Opioid Agonist/Antagonist3.9%
    Butorphanol Tartrate100%
    Part D<11 patients
    Opioid Agonist3.4%
    Oxycodone-Acetaminophen100%
    Part D<11 patients
All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

11 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

John R. Asplin36John C. Lieske23Frank Modersitzki21Robert S. Hoffman18Huilin Li18Lama Nazzal15Fredric L. Coe14David E. St‐Jules13Valéry Lavergne12Sophie Gosselin12Thomas D. Nolin12Marc Ghannoum12Darren M. Roberts10Dawn S. Milliner10Mary Ann Sevick10Lada Beara‐Lasić9Joan H. Parks9Mary Lou Pompeii9Kamyar Kalantar‐Zadeh9Kurt Anseeuw9Michael Grasso9Brian H. Eisner9Gregory E. Tasian9Peter C. Harris8James B. Mowry8James E. Lingeman8Jan T. Kielstein8Erik Kvam8James S. Kaufman8Aditya Mattoo8Gary C. Curhan8Bruno Mégarbane8Roy H. Doi8Diane P. Calello8N. I. Shul'ga7Shivam Joshi7Chris Yates7Taís Freire Galvão7Stuart D. Katz7Jonathan I. Millen7

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/david-goldfarb-md-4d5caa3e

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Other

    nyulangone.org/doctors/1629018908/david-s-goldfarb

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/NKFGNY/videos/dr-goldfarb-clinical-chief-of-nephrology-at-nyu-langone-medical-center-presented/10155150078859874

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Other

    asn-online.org/about/bio.aspx

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • President

    ROCK Society

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rocksociety.org ↗
  • Vice-Chair

    AUA Guideline Panel on Medical Management of Kidney Stones, representing ASN

    2014
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pubmed.ncbi.nlm.nih.gov ↗
  • President

    NY Society of Nephrology

    1999
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
  • Editorial Board Member

    Kidney International

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
  • Editorial Board Member

    Current Opinion in Nephrology and Hypertension

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
  • Former Associate Editor

    Clinical Journal of the American Society of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • Medical Advisory Board

    National Kidney Foundation Greater New York

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • Scientific Advisory Board

    Oxalosis and Hyperoxaluria Foundation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • Board of Directors

    International Cystinuria Foundation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • Fellow

    American Society of Nephrology (FASN)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
  • ASN Representative

    ISN GREEN-K Initiative

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
  • Chair

    ASN Sustainability Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
  • NKF Representative

    EXTRIP Workgroup

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗

Awards & honors

honors on the public record
  • Nephrologist of the Year

    American Kidney Fund

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • Stone Crusher of the Year

    Oxalosis and Hyperoxaluria Foundation

    2014
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗

Secondary affiliations

appointments beyond the home institution
  • Chief

    Nephrology Section, VA New York Harbor Healthcare System

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • Medical Director

    Hemodialysis Unit, VA New York Harbor Healthcare System

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • Director

    Kidney Stone Prevention Program, NYU Langone Health and New York VA Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.